[Value of oncologic follow-up of patients operated for colorectal cancer. A prospective study of 1000 patients]

J Chir (Paris). 1997 Jul;134(2):45-50.
[Article in French]

Abstract

Objective: The purpose of our prospective study was to evaluate the contribution of follow-up in resected colorectal cancer.

Methods: One-thousand patients with colorectal adenocarcinoma who underwent radial resection from January 1975 to January 1990 were prospectively divided into two groups: the first group (n = 442, 42%) entered a 5-year follow-up protocol and the second group (n = 558, 56%) was free to make unscheduled visits in case of symptoms.

Results: Recurrence was found in 31.5% of the patients in the first group compared with 33% in the second group. Chorioembryonic antigen was the most accurate test detecting recurrence: 77% of the cases (97% for hepatic metastasis). Surgical resection of recurrent tumors was performed in 37% of the group 1 patients (curative resection in 15%) and in 9% (curative resection in 1.5%) of the group 2 patients (p < 0.001). 5-year survival after recurrence in group 1 was 11.5% versus 1% in group 2 (p < 0.01).

Conclusion: These results emphasize the rational for a follow-up program in patients undergoing surgery for colorectal cancer.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Actuarial Analysis
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoembryonic Antigen / blood*
  • Colonic Neoplasms / mortality
  • Colonic Neoplasms / pathology
  • Colonic Neoplasms / surgery*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Metastasis
  • Neoplasm Recurrence, Local / surgery
  • Neoplasm Staging
  • Prospective Studies
  • Rectal Neoplasms / mortality
  • Rectal Neoplasms / pathology
  • Rectal Neoplasms / surgery*
  • Survival Rate
  • Treatment Outcome

Substances

  • Carcinoembryonic Antigen